MedPath

TEVA-RALOXIFENE

TEVA-RALOXIFENE

Discontinued
DIN Number

02312298

Drug Class

Human

Market Date

Jul 28, 2009

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02312298
AIG Number0151607001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G03XC01 RALOXIFENE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification68:16.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

RALOXIFENE HYDROCHLORIDEActive
Strength: 60 MG
Monograph: RALOXIFENE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.